The results indicated that 25% of high-grade endometrioid tumors and serous tumors had extensive changes in copy number, few DNA methylation alterations, frequent p53 mutations and low levels of the estrogen and progesterone receptors. The gene discussed is PGR; the disease is endometrioid tumor.